Chemotherapy and chemoprophylaxis of experimental toxoplasmosis.
D000208:Acute Disease; D000818:Animals; D001921:Brain / Q000382:microbiology; D002908:Chronic Disease; D004338:Drug Combinations; D051379:Mice; D002727:Proguanil / Q000627:therapeutic use; D011739:Pyrimethamine / Q000627:therapeutic use; D011743:Pyrimidines / Q000627:therapeutic use; D013411:Sulfadiazine / Q000627:therapeutic use; D013449:Sulfonamides / Q000627:therapeutic use; D013450:Sulfones / Q000627:therapeutic use; D014122:Toxoplasma / Q000302:isolation & purification; D014123:Toxoplasmosis / Q000188:drug therapy* / Q000517:prevention & control
D004338:Drug Combinations; D011743:Pyrimidines; D013449:Sulfonamides; D013450:Sulfones; D013411:Sulfadiazine; D002727:Proguanil; D011739:Pyrimethamine